Stratipath Secures Spot on Prestigious 33-List of Top Innovative Tech Companies for Third Consecutive Year
Stratipath has been recognized as one of the Gold Companies on NyTeknik – First with news about technology and IT. and Affärsvärlden’s prestigious 33-list – for the maximum three consecutive years!
Article in ”Oncology in Sweden” on the continuation of SwAIPP (Sweden AI Precision Pathology)
SwAIPP 2, the continuation of the SwAIPP project, has been funded by Sweden’s innovation agency, Vinnova. We at Stratipath are proud to be partners in this consortium alongside leaders in academia, healthcare, and industry.
Podcast: “Precision Medicine is the Future of Healthcare – But Do We Have the Skills Needed?”
Johan Hartman is a guest at the Johnson & Johnson podcast “Vi forskar för livet” (“Research for Life”). The episode, titled “Precision Medicine is the Future of Healthcare – But Do We Have the Skills Needed?”
Article at Genomeweb: ”Stratipath Seeks to Ramp up Adoption of AI-Based Breast Cancer Test”
Johan Hartman is a guest at the Johnson & Johnson podcast “Vi forskar för livet” (“Research for Life”). The episode, titled “Precision Medicine is the Future of Healthcare – But Do We Have the Skills Needed?”
TV4 morning show: Report: New Drugs Are Not Reaching All Breast Cancer Patients
Advances in breast cancer research are providing entirely new opportunities to diagnose and treat the most common cancer among women. Today, the Breast Cancer Association is releasing a report on access to the advanced diagnostic methods needed to determine whether a patient will benefit from specific medications, known as precision diagnostics. Susanne Dieroff Hay, Chair of the Breast Cancer Association, and Johan Hartman, tumor pathologist at Karolinska University Hospital, share their insights.
Unilabs Sverige and St. Göran’s Hospital are soon adopting Stratipath Breast for breast cancer risk profiling.
Johan Hartman is a guest at the Johnson & Johnson podcast “Vi forskar för livet” (“Research for Life”). The episode, titled “Precision Medicine is the Future of Healthcare – But Do We Have the Skills Needed?”
Article in Impact loop.
“We have the first product in this field approved for hospital use. But AI is advancing rapidly, so there will be competition, which is great. The market is large, so there’s room for more players.”
Swelife conducted an interview with our Chief Medical Officer and co-founder Johan Hartman
Swelife conducted an interview with our Chief Medical Officer and co-founder Johan Hartman
Stratipath co-founder Professor Johan Hartman, is discussing the future of precision diagnostics in Medtech Magazine
Stratipath co-founder Professor Johan Hartman, is discussing the future of precision diagnostics in Medtech Magazine
Interview with Stratipath CTO Mattias Rantalainen about SwAIPP
Mattias Rantalainen, co-founder, CTO of Stratipath, and coordinator of SwAIPP (Sweden AI Precision Pathology), is being interviewed by Vinnova regarding innovation in precision medicine. “For us, building evidence around the solutions we develop is important. We collaborate internationally in several ongoing validation studies. We also gain synergies by conducting overlapping activities with a Nordic consortium. […]